Patients co-infected with hepatitis C virus (HCV) and human immunodeficiency virus recover genotype cross-reactive neutralising antibodies to HCV during antiretroviral therapy

QR Code

Patients co-infected with hepatitis C virus (HCV) and human immunodeficiency virus recover genotype cross-reactive neutralising antibodies to HCV during antiretroviral therapy

When severely immunodeficient HIV/HCV co-infected patients are treated with antiretroviral therapy, it is important to know whether HCV-specific antibody responses recover and whether antibody profiles predict the occurrence of HCV-associated immune restoration disease (IRD). In 50 HIV/HCV co-infect...

Full description

Bibliographic Details
Main Authors:	Lee, S., Saraswati, H., Yunihastuti, E., Gani, R., Price, Patricia
Format:	Journal Article
Published:	Academic Press 2014
Subjects:	Genotype cross-reactive neutralising antibody Antiretroviral therapy HIV HCV
Online Access:	http://hdl.handle.net/20.500.11937/21202

Similar Items

Generation of human monoclonal antibodies: the development of methods to identify and isolate neutralising antibodies targeted to Ebolavirus from peripheral blood
by: Bailey, Graham D.
Published: (2017)

Immune responses to hepatitis C virus (HCV): investigation of the role of L-ficolin and anti-E1E2
by: Hamed, Mohamed R.
Published: (2009)

Hepatitis C virus quasispecies and pseudotype analysis from acute infection to chronicity in HIV-1 co-infected individuals
by: Ferns, R. Bridget, et al.
Published: (2016)

Papular pruritic eruption of human immunodeficiency virus infection
by: Chua, Ser Ling
Published: (2015)

The dynamics of HCV-specific antibody responses in HIV/HCV patients on long-term antiretroviral therapy
by: Lee, S., et al.
Published: (2017)

Periportal CD4+ Cell Infiltration Increases in HIV/Hepatitis C Virus–Coinfected Patients Commencing ART, Whereas CD8+ Cells Clear From the Liver
by: Gani, R., et al.
Published: (2014)

Isolation and characterisation of bovine ultralong antibodies to SARS-CoV-2 using phage display
by: Park, Emily
Published: (2024)

Mesenteric Lymphatic Targeting of Antiretroviral agents for Improved Treatment of HIV/AIDS
by: Chu, YenJu
Published: (2023)

Antibody and markers of T-cell activation illuminate the pathogenesis of HCV immune restoration disease in HIV/HCV co-infected patients commencing ART
by: Yunihastuti, E., et al.
Published: (2011)

Tracking HCV protease population diversity during transmission and susceptibility of founder populations to antiviral therapy
by: Khera, Tanvi, et al.
Published: (2017)

Effectiveness of clinician client-centered counseling on knowledge, attitudes and sexual bahaviors of antiretroviral therapy patients in Yola, Nigeria
by: Martins, Olutayo Folashade
Published: (2015)

Long-term virological outcome in children on antiretroviral therapy in the UK and Ireland
by: Duong, Trinh, et al.
Published: (2014)

Detection of HCV-specific IFN-gamma responses in HCV antibody and HCV RNA negative injecting drug users
by: Flynn, J., et al.
Published: (2014)

Knowledge, Attitude and Practices Related to Human Immunodeficiency Virus and Acquired Immunodeficiency Syndrome Among Students in Universiti Putra Malaysia
by: Rahnama, Rozina
Published: (2009)

The interface between adaptive and innate neutralisation of virus entry: competition, addition or synergy?
by: Wartnaby, Sophie R.
Published: (2023)

Factors associated with human immunodeficiency virus stigma (HIV) among health care workers in Hulu Langat, Selangor
by: Che Ishak, Natalia
Published: (2017)

Hepatitis C virus (HCV) diagnosis via microfluidics
by: Narayanamurthy, Vigneswaran, et al.
Published: (2021)

Few Liver-Infiltrating Cells Express CXCR3 in HIV/HCV Patients Commencing Antiretroviral Therapy.
by: Marini, S., et al.
Published: (2016)

The optimisation of Pseudotyped viruses for the characterisation of immune responses to equine influenza virus
by: Scott, Simon D., et al.
Published: (2016)

Targeting Lopinavir to the Mesenteric Lymphatic System by Lipophilic Ester Prodrug Approach for Improved Treatment of HIV/AIDS
by: Qin, Chaolong
Published: (2021)

Prevalence and factors associated with erectile dysfunction among males with human immunodeficiency virus in a tertiary teaching hospital in Malaysia
by: Enoma, Aghahowa
Published: (2016)

Localization of the antigenic sites of Newcastle disease virus nucleocapsid using a panel of monoclonal antibodies
by: Ahmad-Raus, Raha, et al.
Published: (2009)

Ethical Consumerism and Techniques of Neutralisation in the Hybrid Electric Car Market: An Application of the Theory of Planned Behaviour
by: Biddle, Tom
Published: (2008)

Contributing factors towards adherence to antiretroviral therapy among people living with HIV at a University Teaching Hospital in Nigeria
by: Eze, Rosemary Ada
Published: (2022)

Characterization of occult hepatitis c virus (hcv) infection among hemodialysis patient
by: Abdul Rahman, Siti Nurul Fazlin, et al.
Published: (2017)

Association of beta-defensin gene copy number variation with CD4 count and viral load among Malaysian ethnics hiv patients after HAART initiation
by: Achim, Nurfarahin Hanini
Published: (2020)

Experimental design of a novel target to isolate HCV monoclonal antibodies
by: Brice, Sophie
Published: (2014)

Cohort profile: the Hepatitis C Virus (HCV) Research UK clinical database and biobank
by: McLauchlan, John, et al.
Published: (2017)

Increased proportions of dendritic cells and recovery of IFNγ responses in HIV/HCV co-infected patients receiving ART
by: Saraswati, H., et al.
Published: (2015)

Mapping Of Nucleocapsid Protein (Np) Epitopes and Np-Phosphoprotein Interactive Domains of Newcastle Disease Virus with Np Monoclonal Antibodies
by: Ahmad Raus, Raha
Published: (2006)

Analysis of diversity of hepatitis C virus glycoproteins E1 and E2
by: Hudson, Natalia Joanna
Published: (2012)

Could a loss of memory T cells limit responses to hepatitis C virus (HCV) antigens in blood leucocytes from patients chronically infected with HCV before and during pegylated interferon-a and ribavirin therapy?
by: Lee, S., et al.
Published: (2010)

Production, characterization and scaling up of monoclonal antibodies against neuraminidase glycoprotein of avian influenza virus subtype H9N2
by: Abdelaziz Fadul, Sana Awad
Published: (2011)

HCV genotypes in haemodialysis units: a preliminary study
by: Hamzah, Hairul Aini, et al.
Published: (2008)

Probing the interaction of Hepatitis C virus glycoproteins with putative receptors and neutralising antibodies
by: Mirza, Deeman
Published: (2012)

CD56+ lymphocyte counts remain low in the livers of human immunodeficiency virus/hepatitis C virus patients commencing ART
by: Susufi, Y., et al.
Published: (2015)

Biodynamics of HCV infection in haemodialysis patients in Pahang
by: Mustafa Mahmoud, Mohammed Imad Al-Deen, et al.
Published: (2011)

Biodynamics of HCV infection in haemodialysis patients in Pahang
by: Mustafa Mahmoud, Mohammed Imad Al-Deen, et al.
Published: (2010)

Enhanced nanoparticle uptake into virus infected cells: could nanoparticles be useful in antiviral therapy?
by: Abo-zeid, Yasmin, et al.
Published: (2018)

Predictors of adherence to antiretroviral therapy among human immunodeficiency virus patients in Jos University Teaching Hospital, Nigeria
by: Panmial, P. D., et al.
Published: (2019)

Cannot write session to /tmp/vufind_sessions/sess_ji15jkpnd96lnso1vkemv5gm3l